Company Filing History:
Years Active: 2012
Title: Innovations by Ying-Chen Leu in Diabetes Management
Introduction
Ying-Chen Leu is a notable inventor based in Tainan County, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the area of diabetes management. His innovative work focuses on the development of compositions that can improve the syndrome of diabetes and its complications.
Latest Patents
Ying-Chen Leu holds a patent for a composition that utilizes specific Lactobacillus strains to enhance the management of diabetes. The patent, titled "Lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof," describes a formulation that includes an effective amount of strains selected from GMNL-89, GMNL-205, and GMNL-263, along with a pharmaceutical acceptable vehicle. Notably, the GMNL-205 and GMNL-263 strains are novel isolated strains that have shown promise in improving diabetes-related conditions.
Career Highlights
Ying-Chen Leu is associated with Genmont Biotech Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to finding innovative solutions for health challenges, particularly those related to metabolic disorders.
Collaborations
Ying-Chen Leu collaborates with Feng-Ching Hsieh, contributing to the advancement of their shared goals in biotechnology and health improvement.
Conclusion
Ying-Chen Leu's innovative contributions to diabetes management through his patented compositions highlight the potential of biotechnology in addressing significant health issues. His work exemplifies the importance of research and collaboration in the pursuit of effective treatments for chronic conditions.